ProstaLund AB (publ) (PLUN.ST)
SEK 0.22
(-3.86%)
SEK 0.22
(-3.86%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -16.85 Million SEK | -52.13% |
| 2022 | -10.89 Million SEK | -38.68% |
| 2021 | -7.85 Million SEK | 20.81% |
| 2020 | -9.91 Million SEK | 4.97% |
| 2019 | -10.43 Million SEK | 19.4% |
| 2018 | -12.95 Million SEK | 23.37% |
| 2017 | -16.9 Million SEK | -43.11% |
| 2016 | -11.8 Million SEK | -23.65% |
| 2015 | -9.55 Million SEK | -22.25% |
| 2014 | -7.81 Million SEK | -70.31% |
| 2013 | -4.58 Million SEK | -185.79% |
| 2012 | -1.6 Million SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -4.99 Million SEK | -24.97% |
| 2024 Q2 | -7.26 Million SEK | -43.53% |
| 2023 Q3 | -6.24 Million SEK | -53.44% |
| 2023 FY | -16.57 Million SEK | -52.13% |
| 2023 Q1 | -3.17 Million SEK | -0.99% |
| 2023 Q2 | -4.07 Million SEK | -28.19% |
| 2023 Q4 | -3.99 Million SEK | 36.06% |
| 2022 Q2 | -3.62 Million SEK | -69.63% |
| 2022 Q3 | -1.98 Million SEK | 45.19% |
| 2022 Q4 | -3.14 Million SEK | -58.23% |
| 2022 Q1 | -2.13 Million SEK | 4.08% |
| 2022 FY | -10.89 Million SEK | -38.68% |
| 2021 FY | -7.85 Million SEK | 20.81% |
| 2021 Q1 | -1.16 Million SEK | 68.75% |
| 2021 Q3 | -1.69 Million SEK | 38.46% |
| 2021 Q2 | -2.76 Million SEK | -136.79% |
| 2021 Q4 | -2.22 Million SEK | -31.14% |
| 2020 FY | -9.91 Million SEK | 4.97% |
| 2020 Q1 | -1.59 Million SEK | 33.14% |
| 2020 Q2 | -3.11 Million SEK | -95.35% |
| 2020 Q4 | -3.73 Million SEK | -151.08% |
| 2020 Q3 | -1.48 Million SEK | 52.22% |
| 2019 FY | -10.43 Million SEK | 19.4% |
| 2019 Q2 | -3.21 Million SEK | -12.83% |
| 2019 Q1 | -2.84 Million SEK | 16.52% |
| 2019 Q4 | -2.38 Million SEK | -18.93% |
| 2019 Q3 | -2 Million SEK | 37.63% |
| 2018 Q1 | -4.03 Million SEK | 19.03% |
| 2018 Q4 | -3.4 Million SEK | -56.83% |
| 2018 Q3 | -2.17 Million SEK | 34.84% |
| 2018 FY | -12.95 Million SEK | 23.37% |
| 2018 Q2 | -3.33 Million SEK | 17.33% |
| 2017 Q4 | -4.98 Million SEK | -130.65% |
| 2017 FY | -16.9 Million SEK | -43.11% |
| 2017 Q3 | -2.16 Million SEK | 65.76% |
| 2017 Q2 | -6.3 Million SEK | -82.92% |
| 2017 Q1 | -3.44 Million SEK | 9.4% |
| 2016 FY | -11.8 Million SEK | -23.65% |
| 2016 Q3 | -2 Million SEK | 27.56% |
| 2016 Q4 | -3.8 Million SEK | -89.78% |
| 2016 Q1 | -3.22 Million SEK | -61.11% |
| 2016 Q2 | -2.76 Million SEK | 14.19% |
| 2015 FY | -9.55 Million SEK | -22.25% |
| 2015 Q4 | -2 Million SEK | 29.07% |
| 2015 Q3 | -2.82 Million SEK | 1.71% |
| 2015 Q2 | -2.87 Million SEK | -55.3% |
| 2015 Q1 | -1.85 Million SEK | -1.09% |
| 2014 Q2 | -1.77 Million SEK | -2.72% |
| 2014 Q1 | -1.72 Million SEK | 3.58% |
| 2014 FY | -7.81 Million SEK | -70.31% |
| 2014 Q4 | -1.83 Million SEK | 26.36% |
| 2014 Q3 | -2.48 Million SEK | -40.24% |
| 2013 Q2 | -1.15 Million SEK | -2306.25% |
| 2013 Q1 | -48 Thousand SEK | -118.05% |
| 2013 Q3 | -1.59 Million SEK | -38.1% |
| 2013 Q4 | -1.78 Million SEK | -12.16% |
| 2013 FY | -4.58 Million SEK | -185.79% |
| 2012 FY | -1.6 Million SEK | 0.0% |
| 2012 Q3 | -16 Thousand SEK | 0.0% |
| 2012 Q4 | 266 Thousand SEK | 1762.5% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Ambea AB (publ) | 981 Million SEK | 101.718% |
| Attendo AB (publ) | 1.27 Billion SEK | 101.323% |
| Humana AB (publ) | 378 Million SEK | 104.458% |